Moderna Reports Third Quarter 2023 Financial Results and Provides Business Updates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Moderna (MRNA) drops after announcing a $3.1 billion charge, partially due to Covid writedowns
November 2, 2023 6:58 AM EDTModerna (NASDAQ: MRNA) shares fell about 2% in pre-market Thursday trade after the pharma company said its third-quarter results were impacted by a $3.1 billion charge related to resizing and a tax valuation allowance.
It includes $1.3 billion for inventory write-downs related to excess and obsolete COVID-19... More
Moderna (MRNA) Reports Wide Q3 Loss on $3.1B Charge, as Revenues Beat
November 2, 2023 6:36 AM EDTModerna (NASDAQ: MRNA) reported Q3 EPS of ($9.53), which may not compare to the analyst estimate of ($1.90). Revenue for the quarter came in at $1.8 billion versus the consensus estimate of $1.4 billion.
Company has significantly improved future cost of sales by resizing its manufacturing... More
